Last Update Time:
21-Mar-2025 16:00:00
ISIN:
INE049B01025
Sector:
Healthcare
Symbol:
WOCKPHARMA
Wockhardt Limited
₹1,520.20
₹49.95
(3.40%)
▲
Prev. Close
₹1,470.25
Open
₹1,490.00
Close
₹1,518.80
Range
₹1,444.19 - ₹1,596.21
High
₹1,528.95
Low
₹1,470.00
Ind. Close
₹0.00
VWAP
₹1,500.25
The current stock price of Wockhardt Limited is ₹1,520.20, with a target price range between ₹1,444.19 and ₹1,596.21. The stock has experienced a price change of ₹49.95 (3.40%), reflecting recent market volatility.
Today's opening price was ₹1,490.00, while the previous close stood at ₹1,470.25.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Wockhardt Limited Price Chart
Wockhardt Limited Pre Open Market Overview: 21-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1490
- Previous Close Price: 1470.25
- Change: 19.75%
- Total Traded Volume: 2,767
- Total Buy Quantity: 5,122
- Total Sell Quantity: 16,431
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 1,476.00 | 1.00 | 0.00 |
| 1,477.60 | 50.00 | 0.00 |
| 1,481.00 | 5.00 | 0.00 |
| 1,485.00 | 50.00 | 0.00 |
| 1,488.00 | 5.00 | 0.00 |
| 1,490.00 | 0.00 | 3,630.00 |
| 1,493.00 | 0.00 | 1,500.00 |
| 1,494.00 | 0.00 | 100.00 |
| 1,495.00 | 0.00 | 6.00 |
| 1,495.90 | 0.00 | 1.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 5122
Total Sell Quantity: 16431
Shareholding Patterns of Wockhardt Limited
Key Trade Statistics of Wockhardt Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 6.71 |
| Traded Value (₹ Cr.) | 100.60 |
| Total Market Cap (₹ Cr.) | 24,701.06 |
| Free Float Market Cap (₹ Cr.) | 12,526.25 |
| Impact cost | 0.73 |
| Quantity Traded | 670,587.00 |
| Deliverable Quantity | 350,764.00 |
| % of Quantity to Traded | 52.31 |
| Security VaR | 22.63 |
| Index VaR | N/A |
| VaR Margin | 22.63 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 26.13 |
| Face Value | 5 |
Key Price Statistics of Wockhardt Limited
The 52-week high for Wockhardt Limited was ₹1,679.90, recorded on 06-Feb-2025. On the other hand, the 52-week low stands at ₹490.15, with the lowest value recorded on 05-Jun-2024.
The upper band for trading is ₹1,543.75, and the lower band is ₹1,396.75. The price band is 5%.
The stock's daily volatility stands at 3.40, while the annualized volatility is 64.96. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (06-Feb-2025) | 1,679.90 |
| 52 Week Low (05-Jun-2024) | 490.15 |
| Upper Band | 1,543.75 |
| Lower Band | 1,396.75 |
| Price Band (%) | 5 |
| Daily Volatility | 3.40 |
| Annualised Volatility | 64.96 |
| Tick Size | 0.05 |
Key Securities Statistics of Wockhardt Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 23-Feb-2000 |
| Adjusted P/E | 0 |
| Symbol P/E | 0 |
| Index | NIFTY TOTAL MARKET |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Wockhardt Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Wockhardt Limited
| Subject | Date |
|---|---|
| Alteration Of Capital and Fund Raising-XBRL | 14-Feb-2025 |
| ESOP/ESOS/ESPS | 14-Feb-2025 |
| Integrated Filing- Financial | 07-Feb-2025 |
| Statement of deviation(s) or variation(s) under Reg. 32 | 07-Feb-2025 |
| Monitoring Agency Report | 07-Feb-2025 |
| Press Release | 07-Feb-2025 |
| Financial Result Updates | 07-Feb-2025 |
| Board Meeting Intimation | 03-Feb-2025 |
Corporate Actions of Wockhardt Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 5 | Annual General Meeting | 21-Jun-2024 |
| 5 | Annual General Meeting | 07-Aug-2023 |
| 5 | Rights 3:10@ Premium Rs 220 Per Share | 08-Mar-2022 |
| 5 | Annual General Meeting | 23-Jul-2021 |
| 5 | Annual General Meeting | 24-Jul-2020 |
| 5 | Annual General Meeting | 02-Aug-2019 |
| 5 | Annual General Meeting | 25-Jul-2018 |
| 5 | Annual General Meeting | 24-Jul-2017 |
| 5 | Interim Dividend Rs 10/- Per Share (Purose Revised) | 17-Nov-2016 |
| 5 | Annual General Meeting | 04-Aug-2016 |
| 5 | Annual General Meeting | 03-Sep-2015 |
| 5 | Interim Dividend - Rs 20/- Per Share | 13-Nov-2014 |
| 5 | Annual General Meeting | 04-Sep-2014 |
| 5 | Interim Dividend - Rs 5/- Per Share | 17-Feb-2014 |
| 5 | Interim Dividend Rs.5/- Per Share | 07-Nov-2013 |
| 5 | Annual General Meeting / Dividend Rs.5 Per Share | 22-Aug-2013 |
| 5 | Annual General Meeting | 03-Sep-2012 |
| 5 | Annual General Meeting | 30-Aug-2011 |
| 5 | Annual General Meeting | 08-Sep-2010 |
| 5 | Annual General Meeting | 19-Jun-2009 |
Board Meetings of Wockhardt Limited
Financial Results of Wockhardt Limited
Company Directory of Wockhardt Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Registered Office | Wockhardt Research Centre, D-4,. M.I.D.C, Chikalthana, | AURANGABAD |
| N/A | Transfer Agent | Link Intime India Private Limited Pannalal Silk Mills Compound, 1st Floor, LBS Marg, Bhandup(W), | MUMBAI |
Insider Trading of Wockhardt Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Muayyad Khorakiwala | 0 | Buy |
| 7(2) | Themisto Trustee Company Private Limited | 544881000 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 1776516500 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 748505000 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 174220000 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 624105000 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 47069400 | Pledge Revoke |
| 7(2) | Themisto Trustee Company Private Limited | 79838000 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 499814000 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 216319366 | Sell |
| 7(2) | Ananke Trustee Company Private Limited | 119733444 | Sell |
| 7(2) | Pasithee Trustee Company Private Limited | 202951839 | Sell |
| 7(2) | Themisto Trustee Company Private Limited | 220707704 | Sell |
| 7(2) | Akhilesh Gupta | 4393339 | Buy |
| 7(2) | Themisto Trustee Company Private Limited | 166180000 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 992718250 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 14656500 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 477650000 | Pledge |
| 7(2) | Themisto Trustee Company Private Limited | 55760000 | Pledge Revoke |
| 7(2) | Themisto Trustee Company Private Limited | 87127500 | Pledge Revoke |
Annual Reports of Wockhardt Limited
Investor Complaints of Wockhardt Limited
Event Calendar of Wockhardt Limited
| Purpose | Details |
|---|---|
| Results/Others | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on August 09, 2011, inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2011. The Company has now informed the Exchange that at the aforesaid Board Meeting the Board may also consider implementation of Employees Stock Option Scheme. (Purpose Revised). |
| Results/Dividend | The Company had informed the Exchange regarding a Board meeting to be held on May 22 2012 inter alia, to consider and approve the audited financial results of the Company for the quarter and year ended March 31, 2012. The Company has now informed the Exchange that at the Board Meeting scheduled to be held on May 22, 2012, the Board of Directors of the Company shall also consider recommendation of dividend @ 0.01% (Rs.0.0005 per preference share of Rs. 5/- each) on Non-Convertible Cumulative Redeemable Preference shares of Rs.5/- each and Optionally Convertible Cumulative Redeemable Preference Shares Rs.5/- each absorbing a sum of Rs.21.75 lakhs, on cumulative basis.(Purpose Revised). |
| Results | Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2012. |
| Results/Dividend | Inter alia, to consider and approve the following: (1) Approval of the Audited Consolidated and Standalone financial results of the Company for the quarter and year ended March 31, 2013. (2) Recommendation of dividend on preference shares and equity shares. Further the Company has informed that, in the Audit Committee meeting scheduled to be held on, May 27, 2013, the appointment of Mr. V. Suresh as President - Finance will also be considered. |
| Results | Inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2013. |
| Results/Dividend | Inter alia, for the following:(1) To consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2013 .(2) Consideration of Interim Dividend. |
| Results/Dividend | Inter alia, for the following:(1) To consider and approve the unaudited financial results of the Company for the quarter and nine month ended December 31, 2013 .(2) Consideration of Interim Dividend. |
| Results/Dividend | 26-MAY-2014 : Inter alia, to consider and approve the following items:(1). Approval of the Annual Audited Consolidated and Standalone Accounts of the Company for the year ended March 31, 2014. (2). Approval of the Audited Consolidated and Standalone financial results of the Company for the quarter and year ended March 31, 2014.(3). Recommendation of dividend on preference shares.Further, pursuant to Company's code for prevention of insider trading, the Trading window is closed from May 14, 2014 to May 27, 2014 (both days inclusive). The Trading Window shall re-open 24 hours after the financial results and intimation of dividend are submitted to the stock exchanges |
| Results | Inter alia, to consider and approve the unaudited financial results (consolidated and standalone) of the Company for the quarter ended June 30, 2014. Further, pursuant to Company's code for prevention of insider trading, the Trading window is closed from July 31, 2014 to August 13, 2014 (both days inclusive). The Trading Window shall re-open 24 hours after the financial results are submitted to the stock exchanges. |
| Amalgamation/Merger | Inter alia to consider and approve amalgamation of two wholly owned subsidiaries viz Wockhardt Biopharm Limited and Vinton Healthcare Limited with Wockhardt Limited |
| Results/Dividend | Inter-alia to consider and approve for following matters : 1. To consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the second quarter and half year ended September 30, 2014. 2. To consider and recommend Interim Dividend, if any. |
| Results | Inter alia to consider and approve the unaudited financial results (consolidated and standalone) of the Company for the third quarter and nine months ended December 31, 2014. |
| Results/Others | Inter-alia to consider the following items: 1) Approval of the Annual Audited Consolidated and Standalone Financial Statements of the Company for the year ended March 31, 2015 and Boards Report along with other Annexures, 2) Approval of the Audited Consolidated and Standalone financial results of the Company for the fourth quarter and year ended March 31, 2015 as per Clause 41 of the Listing Agreement and 3) Recommendation of dividend on Preference Shares, if any. |
| Results | inter alia for the approval of unaudited financial results (consolidated and standalone) of the Company for the quarter ended June 30, 2015. |
| Results | Inter alia for the approval of unaudited financial results (consolidated and standalone) of the Company for the quarter and half year ended September 30, 2015. |
| Results | inter-alia, to consider and approve the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter and nine months ended 31st December, 2015. |
| Results/Others | inter-alia, to consider & approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2016; and issuance of Non-Convertible Debentures on private placement basis. |
| Results/Dividend | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held On May 06, 2016, inter-alia, to consider & approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2016; and issuance of Non-Convertible Debentures on private placement basis. The Company has now informed the Exchange that the Board of Directors of the Company at their meeting to be held on May 06, 2016 to inter-alia, consider recommendation of dividend on Preference Shares also.(Purpose Revised). |
| Results | Inter-alia, to consider & approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2016. |
| Results/Dividend | inter-alia, to consider & approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2016; issuance of Masala Bonds and declaration of interim dividend, if any. It is further informed that pursuant to Regulation 42 of the Listing Regulations, the Record Date for payment of interim dividend, if declared, will be November 19, 2016. Further, please note that pursuant to Company s code of conduct for regulating, monitoring, reporting trading by designated persons, the Trading window for dealing in the shares of the Company will be closed from October 29, 2016 to November 12, 2016 (both days inclusive). The Trading Window shall re-open with effect from November 13, 2016. |
| Results | inter-alia, to consider & approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2016. |
| Results/Dividend | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 04, 2017, inter-alia, to consider and: (i) approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2017; (ii) recommend dividend on Preference Shares; (iii) approve raising of funds through issuance of Non-Convertible Debentures on private placement basis; and (iv) approve raising of funds by issue of Equity Shares, Global Depository Receipts, American depository receipts, Foreign Currency Convertible Bonds, fully convertible debentures, partly convertible debentures, preference shares convertible into Equity Shares, and/or any other financial instruments convertible into Equity Shares (including warrants, or otherwise, in registered or bearer form) and / or any security convertible into equity Shares, combination of any of the aforementioned securities by way of one or more public and/or private offerings, Qualified Institutions Placement and/or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law, subject to such approvals as may be required, and to approve ancillary actions for the above mentioned fund raising.The Company has now informed the Exchange that Board of Directors in the said meeting will also consider seeking approval of the Shareholders of the Company: (i) at the ensuring Annual General Meeting, including Notice thereof, for raising funds through issuance of Non-Convertible Debentures on private placement basis; and (ii) through postal ballot, including Notice thereof, for raising funds by issue of Equity Shares etc. as detailed under point (iv) of the said notice of Board meeting dated April 21, 2017. |
| Results/Dividend | inter-alia, to consider and: (i) approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2017; (ii) recommend dividend on Preference Shares; (iii) approve raising of funds through issuance of Non-Convertible Debentures on private placement basis; and (iv) approve raising of funds by issue of Equity Shares, Global Depository Receipts, American depository receipts, Foreign Currency Convertible Bonds, fully convertible debentures, partly convertible debentures, preference shares convertible into Equity Shares, and/or any other financial instruments convertible into Equity Shares (including warrants, or otherwise, in registered or bearer form) and / or any security convertible into equity Shares, combination of any of the aforementioned securities by way of one or more public and/or private offerings, Qualified Institutions Placement and/or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law, subject to such approvals as may be required, and to approve ancillary actions for the above mentioned fund raising. Further, please note that pursuant to Company s code of conduct for regulating, monitoring, reporting trading by designated persons, the Trading window for dealing in the shares of the Company will be closed from April 22, 2017 to May 06, 2017 (both days inclusive). The Trading Window shall re-open with effect from May 07, 2017. |
| Results | Inter-alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2017. |
| Results | inter-alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2017. |
| Results | Inter-alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2017. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the Unaudited financial results for the quarter ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend/Fund Raising | To consider and approve the financial results for the period ended March 31, 2019, dividend on Preference Shares and Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results/Fund Raising | To consider and approve the financial results for the period ended March 31, 2020 and Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Board meeting Rescheduled | Wockhardt Limited has informed the Exchange that the meeting of the Credit Facilities Committee of the Board of Directors of the Company scheduled to be held on March 24, 2021 , inter-alia, to consider and approve the proposal for raising of funds through issuance of Non-convertible Debentures on private placement basis has been postponed. |
| Fund Raising | Meeting of the Credit Facilities Committee of the Board of Directors of the Company is scheduled to be held on 24th March, 2021, inter-alia, to consider and approve the proposal for raising of funds through issuance of Non-convertible Debentures on private placement basis. |
| Fund Raising | Meeting of the Credit Facilities Committee of the Board of Directors of the Company is scheduled to be held on 21st April, 2021, inter-alia, to consider and approve the proposal for raising of funds through issuance of Non-Convertible Debentures on private placement basis. |
| Fund Raising | Meeting of the Credit Facilities Committee of the Board of Directors of the Company is scheduled to be held on 21st May, 2021, inter-alia, to consider and approve the proposal for raising of funds through issuance of Non-convertible Debentures on private placement basis. |
| Financial Results/Fund Raising | To consider and approve the financial results for the period ended March 31, 2021 and Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Fund Raising | To consider and approve various fund raising options for the Company, as the Board may deem appropriate. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Wockhardt Limited has informed the Exchange about Board Meeting to be held on 04-Nov-2022 to consider financial results for the Quarter and half year ended 30th September 2022 |
| Financial Results | Intimation of the Meeting of Board of Directors of Wockhardt Limited |
| Financial Results/Fund Raising | We wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday, 26th May, 2023, inter-alia, to consider and approve the following:(i) the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and Financial year ended 31st March, 2023; and (ii) raising of funds by various method as may be permitted under applicable law, subject to consent of shareholder at the ensuing Annual General Meeting and such approvals and compliances as may be required, and to approve ancillary actions for the above mentioned fund raising. |
| Financial Results | Intimation of the Meeting of Board of Directors of Wockhardt Limited |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | Intimation of the Meeting of Board of Directors of Wockhardt Limited |
| Fund Raising | Prior intimation of the meeting of Capital Raising Committee of the Company for determination of Issue Price. |
| Financial Results/Fund Raising | Intimation of the meeting of Board of Directors of Wockhardt Limited |
| Financial Results | Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday, 9th August, 2024, inter-alia, to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June, 2024. |
| Financial Results | Intimation of the Meeting of Board of Directors of Wockhardt Limited |
| Financial Results | Intimation of the Meeting of Board of Directors of Wockhardt Limited |
Share Transfers of Wockhardt Limited
Voting Results of Wockhardt Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 28-JUN-2024 | AGM | To receive, consider and adopt:na. the Audited Standalone Financial Statements of the Company for the Financial Year ended March 31, 2024 together with the Reports of the Board of Directors and the Auditors thereon; andnb. the Audited Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2024 together with the Report of the Auditors thereon. |
| 28-JUN-2024 | AGM | Approval for raising of additional capital by way of one or more public or private offerings including through a Qualified Institutions Placement (￢ﾀﾘQIP￢ﾀﾙ) to eligible investors through an issuance of Equity Shares or other eligible securities for an amount not exceeding ￂ 1,000 Crore |
| 28-JUN-2024 | AGM | Appointment of Amb. Ahmad Javed (DIN: 08668304) as an Independent Director of the Company |
| 28-JUN-2024 | AGM | Re-appointment of Dr. Habil Khorakiwala (DIN: 00045608) as an Executive Chairman and Fixing of his Remuneration |
| 28-JUN-2024 | AGM | Approval of Material Related Party Transactions |
| 28-JUN-2024 | AGM | Ratification of remuneration payable to the Cost Auditors for the Financial Year 2024-25 |
| 28-JUN-2024 | AGM | Appointment of M/s. M S K C & Associates, Chartered Accountants as Statutory Auditors of the Company and Fixation of Remuneration |
| 28-JUN-2024 | AGM | To appoint a Director in place of Dr. Huzaifa Khorakiwala (DIN: 02191870), who retires from office by rotation and being eligible, offers himself for re-appointment. |
| 14-AUG-2023 | AGM | Adoption of Audited Financial Statements:nTo receive, consider and adopt:na. the Audited Standalone Financial Statements of the Company for the Financial year ended March 31, 2023 togethernwith the Reports of the Board of Directors and the Auditors thereon; andnb. the Audited Consolidated Financial Statements of the Company for the Financial year ended March 31, 2023 togethernwith the Report of the Auditors thereon. |
| 14-AUG-2023 | AGM | To approve creation of charge on assets of the Company |
| 14-AUG-2023 | AGM | To re-confirm authority to the Board to approve Borrowings upto ￂ 3,000 Crore |
| 14-AUG-2023 | AGM | Approval for raising of additional capital by way of one or more public or private offerings including through anQualified Institutions Placement (￢ﾀﾘQIP￢ﾀﾙ) to eligible investors through an issuance of Equity Shares or other eligiblensecurities for an amount not exceeding ￂ 1,600 Crore |
| 14-AUG-2023 | AGM | Approval of Material Related Party Transactions |
| 14-AUG-2023 | AGM | Approval for re-appointment of Dr. Murtaza Khorakiwala (DIN: 00102650) as Managing Director and Fixation ofnRemuneration |
| 14-AUG-2023 | AGM | Approval for re-appointment of Dr. Huzaifa Khorakiwala (DIN: 02191870) as an Executive Director and Fixation ofnRemuneration |
| 14-AUG-2023 | AGM | Appointment of Ms. Amelia Fernandes as an Independent Director of the Company |
| 14-AUG-2023 | AGM | Ratification of remuneration payable to the Cost Auditors for the Financial Year 2023-24 |
| 14-AUG-2023 | AGM | Appointment of Director retiring by rotation:n To appoint a Director in place of Ms. Zahabiya Khorakiwala (DIN: 00102689), who retires from office by rotation and, beingneligible, offers herself for re-appointment |
| 12-AUG-2022 | AGM | 1 - Adoption of Audited Financial Statement:na) The Audited Standalone Financial Statements of the Company for the Financial Year ended 31st March, 2022 together with the Reports of the Board of Directors and Auditors thereon; andnb) The Audited Consolidated Financial Statements of the Company for the Financial Year ended 31st March, 2022 together with the Report of Auditors thereon. |
| 12-AUG-2022 | AGM | 2 - To appoint a Director in place of Dr. Murtaza Khorakiwala (DIN: 00102650), who retires from office by rotation and, being eligible, offers himself for re-appointment.n |
FAQs on Wockhardt Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.